CRBU Caribou Biosciences Inc
Price (delayed)
$2.11
Market cap
$190.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.4
Enterprise value
$179.59M
Highlights
CRBU's gross profit has soared by 132% YoY
The revenue has surged by 132% year-on-year
The quick ratio is down by 17% since the previous quarter but it is up by 12% year-on-year
The equity rose by 15% YoY but it fell by 10% QoQ
Caribou Biosciences's net income has decreased by 11% YoY and by 7% QoQ
Key stats
What are the main financial stats of CRBU
Market
Valuations
Earnings
Shares outstanding
90.36M
Market cap
$190.67M
Enterprise value
$179.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.61
Price to sales (P/S)
5.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.42
Revenue
$33.11M
EBIT
-$123.25M
EBITDA
-$117.29M
Free cash flow
-$130.95M
Per share
Balance sheet
Liquidity
EPS
-$1.4
Free cash flow per share
-$1.45
Book value per share
$3.44
Revenue per share
$0.37
TBVPS
$4.13
Total assets
$372.94M
Total liabilities
$62.47M
Debt
$26.79M
Equity
$310.46M
Working capital
$239.94M
Debt to equity
0.09
Current ratio
8.75
Quick ratio
8.52
Net debt/EBITDA
0.09
Margins
Efficiency
Dividend
EBITDA margin
-354.2%
Gross margin
100%
Net margin
-372.8%
Operating margin
-427.6%
Return on assets
-29.6%
Return on equity
-34.8%
Return on invested capital
-34.7%
Return on capital employed
-36%
Return on sales
-372.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CRBU stock price
How has the Caribou Biosciences stock price performed over time
Intraday
0.48%
1 week
3.43%
1 month
0.96%
1 year
-59.89%
YTD
-63.18%
QTD
28.66%
Financial performance
How have Caribou Biosciences's revenue and profit performed over time
Revenue
$33.11M
Gross profit
$33.11M
Operating income
-$141.58M
Net income
-$123.44M
Gross margin
100%
Net margin
-372.8%
CRBU's gross profit has soared by 132% YoY
The revenue has surged by 132% year-on-year
Caribou Biosciences's net margin has soared by 52% YoY but it has decreased by 8% from the previous quarter
The company's operating margin rose by 50% YoY but it fell by 9% QoQ
Growth
What is Caribou Biosciences's growth rate over time
Valuation
What is Caribou Biosciences stock price valuation
P/E
N/A
P/B
0.61
P/S
5.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.42
Caribou Biosciences's EPS has increased by 23% YoY and by 4.1% QoQ
The P/B is 45% less than the last 4 quarters average of 1.1
The equity rose by 15% YoY but it fell by 10% QoQ
The revenue has surged by 132% year-on-year
CRBU's P/S is 45% below its last 4 quarters average of 10.5
Efficiency
How efficient is Caribou Biosciences business performance
Caribou Biosciences's return on sales has surged by 52% YoY but it has decreased by 8% QoQ
The ROE has grown by 8% YoY but it has contracted by 4.2% from the previous quarter
CRBU's return on invested capital is up by 6% year-on-year but it is down by 3.3% since the previous quarter
CRBU's ROA is down by 6% since the previous quarter but it is up by 2.3% year-on-year
Dividends
What is CRBU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CRBU.
Financial health
How did Caribou Biosciences financials performed over time
The company's total liabilities fell by 22% YoY
The current ratio has contracted by 17% from the previous quarter but it has grown by 12% YoY
Caribou Biosciences's debt is 91% less than its equity
The equity rose by 15% YoY but it fell by 10% QoQ
Caribou Biosciences's debt to equity has increased by 13% from the previous quarter but it has decreased by 10% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.